BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 6193689)

  • 21. Rescue effect of exogenous reduced folates on methotrexate polyglutamylation and dihydrofolate reductase activity in L1210 cells.
    Balińska M
    Acta Biochim Pol; 1988; 35(3):199-205. PubMed ID: 2469275
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Methotrexate polyglutamate synthesis in lymphoblasts from children with acute lymphoblastic leukemia.
    Whitehead VM; Rosenblatt DS; Vuchich MJ; Beaulieu D
    Dev Pharmacol Ther; 1987; 10(6):443-8. PubMed ID: 2445535
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extracellular recovery of methotrexate-polyglutamates following efflux from L1210 leukemia cells.
    Poser RG; Sirotnak F; Chello PL
    Biochem Pharmacol; 1980 Oct; 29(19):2701-4. PubMed ID: 6158955
    [No Abstract]   [Full Text] [Related]  

  • 24. Metabolic turnover of methotrexate polyglutamates in lysosomes derived from S180 cells. Definition of a two-step process limited by mediated lysosomal permeation of polyglutamates and activating reduced sulfhydryl compounds.
    Barrueco JR; O'Leary DF; Sirotnak FM
    J Biol Chem; 1992 Aug; 267(22):15356-61. PubMed ID: 1379226
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Studies of formation and efflux of methotrexate polyglutamates with cultured hepatic cells.
    Galivan J; Balinska M
    Adv Exp Med Biol; 1983; 163():235-46. PubMed ID: 6193687
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Methotrexate polyglutamates in cultured human cells.
    Rosenblatt DS; Whitehead VM
    Adv Exp Med Biol; 1983; 163():275-85. PubMed ID: 6193690
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction of methotrexate polyglutamates and dihydrofolate during leucovorin rescue in a human breast cancer cell line (MCF-7).
    Allegra CJ; Boarman D
    Cancer Res; 1990 Jun; 50(12):3574-8. PubMed ID: 1692762
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The role of methotrexate and dihydrofolate polyglutamates in the enhancement of fluorouracil action by methotrexate.
    Fernandes DJ; Moroson BA; Bertino JR
    Cancer Treat Rep; 1981; 65 Suppl 1():29-35. PubMed ID: 6173121
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Formation and retention and biological activity of N10-propargyl-5,8-dideazafolic acid (CB3717) polyglutamates in L1210 cells in vitro.
    Sikora E; Jackman AL; Newell DR; Calvert AH
    Biochem Pharmacol; 1988 Nov; 37(21):4047-54. PubMed ID: 2461200
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Biochemical and pharmacokinetic effects of leucovorin after high-dose methotrexate in a murine leukemia model.
    Sirotnak FM; Donsbach RC; Moccio DM; Dorick DM
    Cancer Res; 1976 Dec; 36(12):4679-86. PubMed ID: 1087182
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methotrexate metabolism by bone marrow cells from patients with leukemia.
    Whitehead VM; Rosenblatt DS
    Adv Exp Med Biol; 1983; 163():287-303. PubMed ID: 6193691
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Antifolate polyglutamylation and competitive drug displacement at dihydrofolate reductase as important elements in leucovorin rescue in L1210 cells.
    Matherly LH; Barlowe CK; Goldman ID
    Cancer Res; 1986 Feb; 46(2):588-93. PubMed ID: 2416428
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Predictions of a network thermodynamics computer model relating to the mechanism of methotrexate rescue by 5-formyltetrahydrofolate and to the importance of inhibition of thymidylate synthase by methotrexate-polyglutamates.
    White JC
    Adv Exp Med Biol; 1983; 163():305-26. PubMed ID: 6193692
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In situ methotrexate polyglutamate formation in rat tissues.
    Krakower GR; Kamen BA
    J Pharmacol Exp Ther; 1983 Dec; 227(3):633-8. PubMed ID: 6197519
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The kinetics of methotrexate polyglutamation in human breast cancer cells.
    Morrison PF; Allegra CJ
    Arch Biochem Biophys; 1987 May; 254(2):597-610. PubMed ID: 2437860
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A methotrexate-resistant human breast cancer cell line with multiple defects, including diminished formation of methotrexate polyglutamates.
    Cowan KH; Jolivet J
    J Biol Chem; 1984 Sep; 259(17):10793-800. PubMed ID: 6206061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of methotrexate polyglutamylation in L1210 leukemia cells when influx is mediated by the reduced folate carrier or the folate receptor. Lack of evidence for influx route-specific effects.
    Spinella MJ; Brigle KE; Freemantle SJ; Sierra EE; Goldman ID
    Biochem Pharmacol; 1996 Sep; 52(5):703-12. PubMed ID: 8765468
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Formation of methotrexate polyglutamates in rat hepatocytes.
    Gewirtz DA; White JC; Randolph JK; Goldman ID
    Cancer Res; 1979 Aug; 39(8):2914-8. PubMed ID: 455278
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Regulation of methotrexate polyglutaminate formation in Ehrlich ascites carcinoma cells by endogenous folate pool.
    Balińska M
    Acta Biochim Pol; 1986; 33(1):31-7. PubMed ID: 2424199
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Similar differential for total polyglutamylation and cytotoxicity among various folate analogues in human and murine tumor cells in vitro.
    Samuels LL; Moccio DM; Sirotnak FM
    Cancer Res; 1985 Apr; 45(4):1488-95. PubMed ID: 3978616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.